Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cronos Group | CRON | Nov 27, 2024 | 2.08 | -0.48 |
Cross Country Healthcare | CCRN | Nov 27, 2024 | 10.80 | +1.31 |
Cross Timbers Royalty Royalty Trust | CRT | Nov 27, 2024 | 11.06 | +1.94 |
CrossAmerica Partners LP Unit | CAPL | Nov 27, 2024 | 20.38 | +0.59 |
CrossFirst Bankshares | CFB | Nov 27, 2024 | 17.57 | -0.34 |
CrowdStrike A | CRWD | Nov 27, 2024 | 347.59 | -4.59 |
Crown Castle | CCI | Nov 27, 2024 | 106.70 | +0.38 |
Crown Crafts | CRWS | Nov 27, 2024 | 4.57 | -0.65 |
Crown ElectroKinetics | CRKN | Nov 27, 2024 | 0.28 | -9.38 |
Crown Holdings | CCK | Nov 27, 2024 | 93.02 | +0.87 |
Crown LNG | CGBS | Nov 27, 2024 | 0.33 | +0.65 |
Cryo-Cell International | CCEL | Nov 27, 2024 | 9.09 | +1.00 |
CryoPort | CYRX | Nov 27, 2024 | 7.09 | -1.25 |
CS Disco | LAW | Nov 27, 2024 | 5.88 | +1.38 |
CSG Systems International | CSGS | Nov 27, 2024 | 54.59 | -0.42 |
CSP | CSPI | Nov 27, 2024 | 15.82 | -4.99 |
CSW Industrials | CSWI | Nov 27, 2024 | 417.23 | -1.50 |
CSX | CSX | Nov 27, 2024 | 36.58 | -0.30 |
CTO Realty Growth | CTO | Nov 27, 2024 | 20.44 | +2.25 |
CTO Realty Growth A Pref | CTO-A | Nov 27, 2024 | 23.53 | +0.06 |
CTS | CTS | Nov 27, 2024 | 54.33 | -0.24 |
CubeSmart | CUBE | Nov 27, 2024 | 50.14 | +0.44 |
Cue Biopharma | CUE | Nov 27, 2024 | 1.22 | +11.93 |
Cullen Frost Bankers B Pref | CFR-B | Nov 27, 2024 | 19.64 | +0.13 |
Cullen/Frost Bankers | CFR | Nov 27, 2024 | 142.38 | -0.37 |
Cullinan Therapeutics | CGEM | Nov 27, 2024 | 13.09 | +2.51 |
Cullman Bancorp | CULL | Nov 27, 2024 | 9.71 | 0.00 |
Culp | CULP | Nov 27, 2024 | 5.18 | -0.19 |
Cumberland Pharmaceuticals | CPIX | Nov 27, 2024 | 1.37 | +23.42 |
Cummins | CMI | Nov 27, 2024 | 371.03 | -1.69 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.